deltatrials
Completed OBSERVATIONAL NCT01706432

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)

Sponsor: University of Chicago

Conditions Central Nervous System Metastases Invasive Ductal Breast Carcinoma Invasive Ductal Breast Carcinoma With Predominant Intraductal Component Invasive Lobular Breast Carcinoma Invasive Lobular Breast Carcinoma With Predominant in Situ Component Liver Metastases Lobular Breast Carcinoma in Situ Lung Metastases Male Breast Cancer Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate Mucinous Ductal Breast Carcinoma Papillary Ductal Breast Carcinoma Recurrent Breast Cancer Stage IV Breast Cancer Tubular Ductal Breast Carcinoma Tumors Metastatic to Brain
Interventions hyperfractionated radiation therapy laboratory biomarker analysis stereotactic radiosurgery
Updated 12 times since 2017 Last updated: Jul 29, 2024 Started: Jun 15, 2009 Primary completion: Jan 22, 2024 Completion: Jan 22, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01706432, this observational or N/A phase trial focuses on Central Nervous System Metastases and Invasive Ductal Breast Carcinoma and remains completed. Sponsored by University of Chicago, it has been updated 12 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotActive Not Recruiting~Jul 2019 – ~Oct 2020 · 15 months · monthly snapshotUnknown Status~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Jan 2022 · 3 months · monthly snapshotActive Not Recruiting~Jan 2022 – ~May 2023 · 16 months · monthly snapshotActive Not Recruiting~May 2023 – ~Jul 2024 · 14 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotActive Not Recruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Aug 2024 — Sep 2024 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  3. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting

  4. May 2023 — Jul 2024 [monthly]

    Active Not Recruiting

  5. Jan 2022 — May 2023 [monthly]

    Active Not Recruiting

    Phase: NA → None

▶ Show 7 earlier versions

  1. Oct 2021 — Jan 2022 [monthly]

    Active Not Recruiting NA

    Phase: PHASE1 → NA

  2. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE1

  3. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

    Status: Unknown Status → Active Not Recruiting · Phase: NA → PHASE1

  4. Jul 2019 — Oct 2020 [monthly]

    Unknown Status NA

    Status: Active Not Recruiting → Unknown Status

  5. Jun 2018 — Jul 2019 [monthly]

    Active Not Recruiting NA

  6. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

  7. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Chicago
Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations